Literature DB >> 15958354

Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry.

A-A Fassa1, P Urban, D Radovanovic, N Duvoisin, J-M Gaspoz, J-C Stauffer, P Erne.   

Abstract

OBJECTIVE: To document the trends in reperfusion therapy for ST segment elevation myocardial infarction (STEMI) in Switzerland.
DESIGN: National prospective multicentre registry, AMIS Plus (acute myocardial infarction and unstable angina in Switzerland), of patients admitted with acute coronary syndromes.
SETTING: 54 hospitals of varying size and capability in Switzerland. PATIENTS: 7098 of 11 845 AMIS Plus patients who presented with ST segment elevation or left bundle branch block on the ECG at admission. MAIN OUTCOME MEASURES: In-hospital mortality and its predictors at admission by multivariate analysis.
RESULTS: The proportion of patients treated by primary percutaneous coronary intervention (PCI) progressively increased from 1997 to 2002, while the proportion with thrombolysis or no reperfusion decreased (from 8.0% to 43.1%, from 47.2% to 25.6%, and from 44.8% to 31.4%, respectively). Overall in-hospital mortality decreased over the study period from 12.2% to 6.7% (p < 0.001). Main in-hospital mortality predictors by multivariate analysis were primary PCI (odds ratio (OR) 0.52, 95% confidence interval (CI) 0.33 to 0.81), thrombolysis (OR 0.63, 95% CI 0.47 to 0.83), and Killip class III (OR 3.61, 95% CI 2.49 to 5.24) and class IV (OR 5.97, 95% CI 3.51 to 10.17) at admission. When adjusted for the year, multivariate analysis did not show PCI to be significantly superior to thrombolysis for in-hospital mortality (OR 1.2 for PCI better, 95% CI 0.8 to 1.9, p = 0.42).
CONCLUSION: Primary PCI has become the preferred mode of reperfusion for STEMI since 2002 in Switzerland, whereas use of intravenous thrombolysis has decreased from 1997 to 2002. Furthermore, there was a major reduction of in-hospital mortality over the same period.

Entities:  

Mesh:

Year:  2005        PMID: 15958354      PMCID: PMC1769002          DOI: 10.1136/hrt.2004.037689

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Low hospital and long-term mortality in a prospective registry of facilitated percutaneous coronary intervention in acute myocardial infarction.

Authors:  Sascha Rux; Kirstin Lenssen; Steffen Sonntag; Torsten Thieme; Leonhard Bruch; Peer-Ekkehart Waurick; Franz Xaver Kleber
Journal:  Am J Cardiol       Date:  2003-07-01       Impact factor: 2.778

2.  From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE).

Authors:  Keith A A Fox; Shaun G Goodman; Frederick A Anderson; Christopher B Granger; Mauro Moscucci; Marcus D Flather; Frederick Spencer; Andrzej Budaj; Omar H Dabbous; Joel M Gore
Journal:  Eur Heart J       Date:  2003-08       Impact factor: 29.983

3.  Facilitated primary percutaneous transluminal coronary angioplasty for acute ST segment elevation myocardial infarction: rationale for reuniting pharmacologic and mechanical revascularization strategies.

Authors:  Ellen C Keeley; Joaquin E Cigarroa
Journal:  Cardiol Rev       Date:  2003 Jan-Feb       Impact factor: 2.644

4.  A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).

Authors:  D Hasdai; S Behar; L Wallentin; N Danchin; A K Gitt; E Boersma; P M Fioretti; M L Simoons; A Battler
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

5.  Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis.

Authors:  R Zahn; R Schiele; A K Gitt; S Schneider; K Seidl; T Voigtländer; M Gottwik; E Altmann; U Gieseler; W Rosahl; S Wagner; J Senges
Journal:  Am Heart J       Date:  2001-07       Impact factor: 4.749

6.  Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR).

Authors:  R Zahn; R Schiele; S Schneider; A K Gitt; H Wienbergen; K Seidl; C Bossaller; H J Büttner; M Gottwik; E Altmann; W Rosahl; J Senges
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

7.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3.

Authors:  W J Rogers; J G Canto; C T Lambrew; A J Tiefenbrunn; B Kinkaid; D A Shoultz; P D Frederick; N Every
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

8.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Authors:  Frans Van de Werf; Diego Ardissino; Amadeo Betriu; Dennis V Cokkinos; Erling Falk; Keith A A Fox; Desmond Julian; Maria Lengyel; Franz-Josef Neumann; Witold Ruzyllo; Christian Thygesen; S Richard Underwood; Alec Vahanian; Freek W A Verheugt; William Wijns
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

9.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

Authors:  P Widimský; T Budesínský; D Vorác; L Groch; M Zelízko; M Aschermann; M Branny; J St'ásek; P Formánek
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

Review 10.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

View more
  5 in total

1.  Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007.

Authors:  Jakob Dörler; Hannes Franz Alber; Johann Altenberger; Gerhard Bonner; Werner Benzer; Georg Grimm; Kurt Huber; Lalit Kaltenbach; Karl-Peter Pfeiffer; Herwig Schuchlenz; Peter Siostrzonek; Gerald Zenker; Otmar Pachinger; Franz Weidinger
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

2.  3-Tesla MRI for the evaluation of myocardial viability: a comparative study with 1.5-Tesla MRI.

Authors:  G Ligabue; F Fiocchi; S Ferraresi; A Barbieri; R Rossi; M G Modena; R Romagnoli; P Torricelli
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

3.  Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry.

Authors:  Dragana Radovanovic; Paul Erne; Philip Urban; Osmund Bertel; Hans Rickli; Jean-Michel Gaspoz
Journal:  Heart       Date:  2007-11       Impact factor: 5.994

4.  Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.

Authors:  Núria Ribas; Cosme García-García; Oona Meroño; Lluís Recasens; Silvia Pérez-Fernández; Víctor Bazán; Neus Salvatella; Julio Martí-Almor; Jordi Bruguera; Roberto Elosua
Journal:  BMC Cardiovasc Disord       Date:  2017-02-07       Impact factor: 2.298

5.  Risk stratification and in-hospital outcome in patients with acute coronary syndrome.

Authors:  Amitkumar V Bhalerao; Sheikh Mohamad Tahir; Rajiv Agarwal
Journal:  J Family Med Prim Care       Date:  2022-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.